TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...

More documents

Recommendations

Info

1.43 Sort P et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:403-9. 1.44 Bhuva M et al. Spontaneous bacterial peritonitis: an update on evaluation, management, and prevention. Am J Med 1994;97:169-75. 1.45 Roehrborn A et al. The microbiology of postoperative peritonitis. Clin Infect Dis 2001;33:1513-9. 1.46 Seguin P et al. Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care. J Antimicrob Chemother 2010;65:342-6. 1.47 Montravers P et al. Clinical and microbiological profiles of community-acquired and nosocomial intraabdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother 2009;63:785-94. 1.48 Eggimann P et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999;27:1066-72. 1.49 Wilson ML et al. Laboratory diagnosis of bone, joint, soft tissue, and skin infections. Clin Infect Dis 2008;46:453-7. 1.50 Pineda C et al. Imaging of osteomyelitis: current concepts. Infect Dis Clin North Am 2006;20:789- 825. 1.51 Lew DP et al. Osteomyelitis. Lancet 2004;364:369-79. 1.52 Lazzarini L et al. Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials? Int J Infect Dis 2005;9:127-38. 1.53 Calhoun JH et al. Adult osteomyelitis. Infect Dis Clin North Am 2005;19:765-86. 1.54 Landersdorfer CB et al. Penetration of antibacterials into bone: pharmacokinetic, pharmaco-dynamic and bioanalytical considerations. Clin Pharmacokinet 2009;48:89-124. 1.55 Ferroni A. Epidémiologie et diagnostic bactériologique des infections ostéoarticulaires aiguës de l'enfant. Arch Pediatr 2007;14(suppl. 2):S91-6. 1.56 Kaplan SL. Osteomyelitis in children. Infect Dis Clin North Am 2005;19:787-97. 1.57 Harik NS et al. Management of acute hematogenous osteomyelitis in children. Expert Rev Anti Infect Ther 2010;8:175-81. 1.58 Dessí A et al. Osteo-articular infections in newborns: diagnosis and treatment. J Chemother 2008; 20:542-50. 1.59 Ecury-Goossen GM et al. Sequential intravenous-oral antibiotic therapy for neonatal osteomyelitis. Pediatr Infect Dis J 2009;28:72-3. 1.60 Chometon S et al. Specific real-time polymerase chain reaction places Kingella kingae as the most common cause of osteoarticular infections in young children. Pediatr Infect Dis J 2007;26:377-81. 1.61 Darouiche RO. Spinal epidural abscess. N Engl J Med 2006;355:2012-20. 1.62 Weichert S et al. Acute haematogenous osteomyelitis in children: is there any evidence for how long we should treat? Curr Opin Infect Dis 2008;21:258-62. 1.63 Zaoutis T et al. Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children. Pediatrics 2009;123:636-42. 1.64 Velissariou IM. The use of fluoroquinolones in children: recent advances. Expert Rev Anti Infect Ther 2006;4:853-60. 1.65 Zimmerli W. Vertebral osteomyelitis. N Engl J Med 2010;362:1022-9. 1.66 Marculescu CE et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006;42:471-8. 1.67 Kowalski TJ et al. The management and outcome of spinal implant infections: contemporary retrospective cohort study. Clin Infect Dis 2007;44:913-20. 1.68 Senneville E et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis 2006;42:57-62. 1.69 Lewis JS et al. Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis 2005;40:280-5. 1.70 Dohin B et al. Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus. Pediatr Infect Dis J 2007;26:1042-8. 1.71 Lovering AM et al. Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement. J Antimicrob Chemother 2002;50:73-7. 1.72 Dohin B et al. Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus. Pediatr Infect Dis J 2007;26:1042-8. 1.73 Paviour S et al. Corynebacterium species isolated from patients with mastitis. Clin Infect Dis 2002; 35:1434-40. 1.74 Moazzez A et al. Breast abscess bacteriologic features in the era of community-acquired methicillinresistant Staphylococcus aureus epidemics. Arch Surg 2007;142:881-4. 1.75 Araco A et al. Infections of breast implants in aesthetic breast augmentations: a single-center review of 3,002 patients. Aesthetic Plast Surg 2007;31:325-9. 1.76 Pittet B et al. Infection in breast implants. Lancet Infect Dis 2005;5:94-106. 1.77 Lu CH et al. Strategies for the management of bacterial brain abscess. J Clin Neurosci 2006;13: 979-85. 1.78 Hakan T et al. Bacterial brain abscesses: an evaluation of 96 cases. J Infect 2006;52:359-66. 1.79 Tonon E et al. Brain abscess: clinical aspects of 100 patients. Int J Infect Dis 2006;10:103-9. 1.80 Roche M et al. A twelve-year review of central nervous system bacterial abscesses; presentation and aetiology. Clin Microbiol Infect 2003;9:803-9. 1.81 de Oliveira Penido N et al. Intracranial complications of otitis media: 15 years of experience in 33 patients. Otolaryngol Head Neck Surg 2005;132:37-42. 1.82 McClelland S et al. Postoperative central nervous system infection: incidence and associated factors in 2111 neurosurgical procedures. Clin Infect Dis 2007;45:55-9. 1.83 Bayston R et al. Use of antibiotics in penetrating craniocerebral injuries. Lancet 2000;355:1813-7. 1.84 Brown-Elliott BA et al. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev 2006;19:259-82. 1.85 Hitti W et al. Two cases of multidrug-resistant Nocardia farcinica infection in immunosuppressed patients and implications for empiric therapy. Eur J Clin Microbiol Infect Dis 2005;24:142-4. 1.86 Gomez-Flores A et al. In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis. Antimicrob Agents Chemother 2004;48:832-7. 1.87 Ntziora F et al. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother 2007;41:296-308. 1.88 Jodlowski TZ et al. Linezolid for the treatment of Nocardia spp. infections. Ann Pharmacother 2007; 41:1694-9.
1.89 Laupland KB. Vascular and parameningeal infections of the head and neck. Infect Dis Clin North Am 2007;21:577-90. 1.90 Osborn MK et al. Subdural empyema and other suppurative complications of paranasal sinusitis. Lancet Infect Dis 2007;7:62-7. 1.91 Tunkel AR et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008;47:303-27. 1.92 Douvoyiannis M et al. Neurologic manifestations associated with parvovirus B19 Infection. Clin Infect Dis 2009;48:1713-23. 1.93 Mailles A et al. Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 2009;49:1838-47. 1.94 Fitch MT et al. Emergency department management of meningitis and encephalitis. Infect Dis Clin North Am 2008;22:33-52. 1.95 Glaser CA et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006;43:1565-77. 1.96 Whitley RJ et al. Viral encephalitis: familiar infections and emerging pathogens. Lancet 2002;359: 507-14. 1.97 Steiner I et al. Viral encephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol 2005;12:1-13. 1.98 Jaussaud R et al. L‘encéphalite virale à tiques. Rev Med Interne 2001;22:542-8. 1.99 Kupila L et al. Etiology of aseptic meningitis and encephalitis in an adult population. Neurology 2006; 66:75-80. 1.100 Christie LJ et al. Pediatric encephalitis: what is the role of Mycoplasma pneumoniae? Pediatrics 2007;120:305-13. 1.101 Bitnun A et al. Acute childhood encephalitis and Mycoplasma pneumoniae. Clin Infect Dis 2001;32: 1674-84. 1.102 Koskiniemi M et al. Acute central nervous system complications in varicella zoster virus infections. J Clin Virol 2002;25:293-301. 1.103 Logan SA et al. Viral meningitis. Br Med J 2008;336:36-40. 1.104 Ihekwaba UK et al. Clinical features of viral meningitis in adults: significant differences in cerebrospinal fluid findings among herpes simplex virus, varicella zoster virus, and enterovirus infections. Clin Infect Dis 2008;47:783-9. 1.105 Douvoyiannis M et al. Neurologic manifestations associated with parvovirus B19 Infection. Clin Infect Dis 2009;48:1713-23. 1.106 Zarrouk V et al. Evaluation of the management of postoperative aseptic meningitis. Clin Infect Dis 2007;44:1555-9. 1.107 Kupila L et al. Etiology of aseptic meningitis and encephalitis in an adult population. Neurology 2006; 66:75-80. 1.108 Logan SA et al. Viral meningitis. Br Med J 2008;336:36-40. 1.109 Moris G et al. The challenge of drug-induced aseptic meningitis. Arch Intern Med 1999;159:1185-94. 1.110 Fitch MT et al. Emergency department management of meningitis and encephalitis. Infect Dis Clin North Am 2008;22:33-52. 1.111 Schut ES et al. Community-acquired bacterial meningitis in adults. Pract Neurol 2008;8:8-23. 1.112 Clarke ET et al. Current concepts in the treatment of bacterial meningitis beyond the neonatal period. Expert Rev Anti Infect Ther 2006;4:663-74. 1.113 Fitch MT et al. Emergency diagnosis and treatment of adult meningitis. Lancet Infect Dis 2007;7: 191-200. 1.114 Adriani KS et al. Community-acquired recurrent bacterial meningitis in adults. Clin Infect Dis 2007; 45:e46-51. 1.115 Hart CA et al. Meningococcal disease and its management in children. Br Med J 2006;333:685-90. 1.116 Sáez-Llorens X et al. Bacterial meningitis in children. Lancet 2003;361:2139-48. 1.117 Tunkel AR al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39:1267-84. 1.118 van de Beek D et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004;351:1849-59. 1.119 van de Beek D et al. Community-acquired bacterial meningitis in adults. N Engl J Med 2006;354:44- 53. 1.120 Kim KS. Acute bacterial meningitis in infants and children. Lancet Infect Dis 2010;10:32-42. 1.121 Tebruegge M et al. Epidemiology, etiology, pathogenesis and diagnosis of recurrent bacterial meningitis. Clin Microbiol Rev 2008;21:519-37. 1.122 Hasbun R et al. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 2001;345:1727-33. 1.123 Pollard AJ et al. Emergency management of meningococcal disease: eight years on. Arch Dis Child 2007;92:283-6. 1.124 Stephens DS et al. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007;369:2196-210. 1.125 Thompson MJ et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet 2006;367:397-403. 1.126 Prasad K et al. Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis. Cochrane Database Syst Rev 2007;4:CD001832. 1.127 O‘Neill E et al. Third-generation cephalosporin resistance among Gram-negative bacilli causing meningitis in neurosurgical patients: significant challenges in ensuring effective antibiotic therapy. J Antimicrob Chemother 2006;57:356-9. 1.128 Ricard JD et al. Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study. Clin Infect Dis 2007;44:250-5. 1.129 Mai NT et al. Immunological and biochemical correlates of adjunctive dexamethasone in Vietnamese adults with bacterial meningitis. Clin Infect Dis 2009;49:1387-92. 1.130 Peltola H et al. Hearing impairment in childhood bacterial meningitis is little relieved by dexamethasone or glycerol. Pediatrics 2010;125:e1-8. 1.131 Peltola H et al. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2007;45:1277-86. 1.132 Assiri AM et al. Corticosteroid administration and outcome of adolescents and adults with acute
Page 1: TABLE 39A LIST OF PUBLICATIONS REFE
Page 5 and 6: of NICE guidance. Br Med J 2008;337
Page 7 and 8: tions à Clostridium difficile dans
Page 9 and 10: sis of placebo-controlled trials. C
Page 11 and 12: 1.446 Centers for Disease Control a
Page 13 and 14: 1.532 Olaison L et al. Enterococcal
Page 15 and 16: 1.615 Muder RR et al. Isolation of
Page 17 and 18: 2005;352:865-74. 1.699 Brown-Elliot
Page 19 and 20: 2009;123:1108-15. 1.782 Ellis MW. A
Page 21 and 22: 1.873 Korting HC et al. Current top
Page 23 and 24: 1.970 Thomas RJ et al. Current mana
Page 25 and 26: of severe respiratory failure. Clin
Page 27 and 28: 1.1166 Aldape MJ et al. Clostridium
Page 29 and 30: 2A.36 Wormser GP. Early Lyme diseas
Page 31 and 32: test methodology. Eur J Clin Microb
Page 33 and 34: 2B.39 Cookson BD et al. Guidelines
Page 35 and 36: 2009;15(suppl. 3):7-11. 2B.115 Jaco
Page 37 and 38: 82. 4A.87 de Smet AM et al. Deconta
Page 39 and 40: after acute pyelonephritis: a multi
Page 41 and 42: for intensive care patients with no
Page 43 and 44: among hospitalized patients. Clin I
Page 45 and 46: Ther 2006;4:947-52. 5D.1 Demirovic
Page 47 and 48: 7.38 Meersseman W et al. Invasive a
Page 49 and 50: 7.121 Walsh TJ et al. All catheter
Page 51 and 52: nail onychomycosis. J Eur Acad Derm
Page 53 and 54:
2006. Clin Infect Dis 2006;43:1580-
Page 55 and 56:
9A.5 Andes D. Pharmacokinetics and
Page 57 and 58:
factor and other newly approved bio
Page 59 and 60:
cument E.DEF 8.1). Report of the Su
Page 61 and 62:
Br J Dermatol 2004;151:1096-100. 11
Page 63 and 64:
new prediction equation. Ann Intern
Page 65 and 66:
14A.93 Sundar S et al. New treatmen
Page 67 and 68:
eview. Obstet Gynecol 2005;105:857-
Page 69 and 70:
2003;1:471-82. 14A.278 Walker MD et
Page 71 and 72:
14B.4 Checkley AM et al. Eosinophil
Page 73 and 74:
18.12 Panel on Antiretroviral Thera
Page 75 and 76:
18.91 Lesho E. Evidence base for us
Page 77 and 78:
tients. J Antimicrob Chemother 2009
Page 79 and 80:
duct characteristics. Available at:
Page 81 and 82:
_Product_Information/human/000338/W
Page 83 and 84:
114:23-33. 21.80 Jabs DA et al. Fom
Page 85 and 86:
North Am 2006;20:155-74. 21.176 Nas
Page 87 and 88:
1995;14:827-32. 21.264 Scott LL. Pe
Page 89 and 90:
21.358 Calabrese LH et al. Viral Ar
Page 91 and 92:
24. 21.452 Jeha LE et al. Long term
Page 93 and 94:
induced functional androgen deficie
Page 95 and 96:
25A.27 Conseil Supérieur de la San
Page 97 and 98:
product characteristics. Available
Page 99 and 100:
mortality after kidney transplantat
Page 101 and 102:
33A.1 Kearney BP et al. The penetra
Page 103 and 104:
Clin Plast Surg Clinics in Plastic
Page 105 and 106:
Mycopathologia Mycopathologia Mycos
show all

TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...

Create successful ePaper yourself

Delete template?

Save as template?